Human loci involved in drug biotransformation: worldwide genetic variation, population structure, and pharmacogenetic implications.
about
A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical PharmacogenomicsApplying genome-wide gene-based expression quantitative trait locus mapping to study population ancestry and pharmacogeneticsGenetic diversity of disease-associated loci in Turkish population.Genetic architectures of ADME genes in five Eurasian admixed populations and implications for drug safety and efficacy.Interethnic DNA methylation difference and its implications in pharmacoepigenetics.
P2860
Human loci involved in drug biotransformation: worldwide genetic variation, population structure, and pharmacogenetic implications.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Human loci involved in drug bi ...... pharmacogenetic implications.
@en
Human loci involved in drug bi ...... pharmacogenetic implications.
@nl
type
label
Human loci involved in drug bi ...... pharmacogenetic implications.
@en
Human loci involved in drug bi ...... pharmacogenetic implications.
@nl
prefLabel
Human loci involved in drug bi ...... pharmacogenetic implications.
@en
Human loci involved in drug bi ...... pharmacogenetic implications.
@nl
P2860
P1433
P1476
Human loci involved in drug bi ...... pharmacogenetic implications.
@en
P2093
Silvia Fuselli
P2860
P2888
P304
P356
10.1007/S00439-013-1268-5
P577
2013-01-26T00:00:00Z